Pediatrix Medical Group Inc

MD remains in a Stage 2 uptrend with higher highs & higher lows, trading in a tight range above the 9/20 EMA stack. The medium-term bias is firmly bullish based on structural continuation, but short-term timing is neutral. Stalk pullbacks into the 9/20 EMA zone for a higher-probability entry.

• ↑Q2 adjusted EBITDA $76M; revenue +4% YoY, 2% same-unit growth
• ↑Building tele-hybrid model, expanding telemedicine services nationwide
• ↓NICU days down 3% and same-unit volumes -2% signal patient decline